tiprankstipranks
Advertisement
Advertisement
Quantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial
PremiumThe FlyQuantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial
1M ago
Quantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial
Premium
The Fly
Quantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial
1M ago
Quantum BioPharma Posts Strong 2025 Results, Extends Cash Runway and Advances MS and Alcohol Health Programs
Premium
Company Announcements
Quantum BioPharma Posts Strong 2025 Results, Extends Cash Runway and Advances MS and Alcohol Health Programs
1M ago
Quantum BioPharma Eases Debenture Terms After Share Price Drop
PremiumCompany AnnouncementsQuantum BioPharma Eases Debenture Terms After Share Price Drop
2M ago
Quantum BioPharma Plans Convertible Debenture Financing and Debt-for-Equity Swap Ahead of 2025 Results
Premium
Company Announcements
Quantum BioPharma Plans Convertible Debenture Financing and Debt-for-Equity Swap Ahead of 2025 Results
2M ago
Quantum BioPharma Completes 180-Day Toxicity Dosing for Lead MS Drug Lucid-MS
Premium
Company Announcements
Quantum BioPharma Completes 180-Day Toxicity Dosing for Lead MS Drug Lucid-MS
4M ago
Quantum BioPharma Moves to Lead Class Action Over Alleged Stock Manipulation by Canadian Banks
PremiumCompany AnnouncementsQuantum BioPharma Moves to Lead Class Action Over Alleged Stock Manipulation by Canadian Banks
5M ago
Quantum BioPharma Closes Private Placement, Enhances Governance
Premium
Company Announcements
Quantum BioPharma Closes Private Placement, Enhances Governance
5M ago
Quantum BioPharma Ends Market Offering Agreement
Premium
Company Announcements
Quantum BioPharma Ends Market Offering Agreement
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100